Dr. Hu Xiang of Beike Biotech was invited to deliver a keynote speech
——”Technological Innovation Promoting the Medical Revolution”
April 14, 2019, byThe 17th China International Talent Exchange Conference·Shenzhen Forum sponsored by the Ministry of Science and Technology (State Administration of Foreign Experts Affairs) and the Shenzhen Municipal People’s Government was held at the Shenzhen Convention and Exhibition Center. Vice Minister of the Ministry of Science and Technology, Zhang Jianguo, Director of the State Administration of Foreign Experts Affairs, Liu Qingsheng, Member of the Standing Committee of the Shenzhen Municipal Committee, Deputy Mayor of the Municipal Government, Party Secretary, and more than 700 experts, scholars, entrepreneurs and business elites from home and abroad gathered together to share the sustainable development and innovation of science and technology and talents under the new international situation, focusing on topics such as “technological innovation” and “talent growth”. [1]
As a person with outstanding contributions in stem cell research and clinical application transformationDr. Hu Xiang, chairman of Beike Biotechnology, was invited to attend this forum and gave a wonderful speech on the theme of “Technological Innovation to Promote the Medical Revolution”. Focusing on the three cores of “people”, “technology” and “life”, he gave an in-depth interpretation of the current cutting-edge fields such as life sciences and biomedical industry, and talked about the prospects for the future direction of medicine.
(Dr. Hu Xiang, Chairman of Beike Biotechnology, delivered a wonderful speech in the forum’s “Technological Innovation Builds Core Competitiveness” section)
Dr. Hu Xiang’s wonderful sharing made the guests present feel the charm of biotechnology and also full of hope for the future development of biomedicine and cell therapy.
At this forum, heavyweight guests such as Jim McDonald and John Speakman, academicians of the Royal Academy of Engineering, Kevin Ashton, the father of the Internet of Things, Hong Weimin, chief liaison officer for Hong Kong affairs of the Qianhai Authority, and Peter Bonfield, president of the University of Westminster, also gave wonderful speeches.
Beike Biotech was founded in July 2005. It is one of the earliest national high-tech enterprises in my country specializing in the clinical transformation and technical services of biotherapeutic technologies in strategic emerging industries.
Beike Biotech has been focusing on the cell field for fourteen years and has a leading R&D team in the field. Currently, it hasApply for 82 patents related to the field of cell technology,33 has been authorized for several projects; published more than 100 papers in authoritative magazines at home and abroad, including Cell Stem Cell; and undertaken more than 60 government projects at all levels, including 6 national-level projects (2 863 projects).
In December 2015, the National Development and Reform Commission approved the construction of the “National and Local Joint Engineering Laboratory for Personalized Cell Therapy Technology” by Beike Biotech. This laboratory is my country’s national technology development and transformation platform to promote the clinical transformation of personalized cell therapy technology.